LPRD vs GERD: Key Differences
Laryngopharyngeal reflux disease (LPRD) and gastroesophageal reflux disease (GERD) are distinct clinical entities, not the same disease—LPRD involves reflux of gastric contents reaching the laryngopharynx and upper airway, while GERD is confined to esophageal reflux, and they differ fundamentally in symptoms, diagnostic approach, and treatment response 1.
Anatomic and Pathophysiologic Distinctions
Location of reflux:
- GERD: Retrograde flow of gastric contents is restricted to the esophagus 2, 3
- LPRD: Gastric contents reach beyond the esophagus into the laryngopharynx and upper aerodigestive tract 1, 2, 3
The two conditions can coexist and mutually influence each other. When GERD is present in LPRD patients, it significantly increases all types of hypopharyngeal reflux events (weak acid, acid, gas, and liquid). Conversely, when LPRD is present in GERD patients, it only increases acidic distal reflux events and acid clearance time 4.
Clinical Presentation Differences
GERD typically presents with:
- Heartburn and regurgitation (approximately 70% sensitive and specific for objective GERD) 5
- Symptoms that respond well to PPI therapy
LPRD characteristically presents with:
- Hoarseness (the most common symptom, especially when lasting >3 months) 2, 3
- Chronic cough 1, 2, 3
- Globus sensation (feeling of throat obstruction) 2, 3
- Excessive throat clearing 1, 2
- Sore throat 3
- Notably, patients with LPRD may NOT complain of heartburn or regurgitation 1
On laryngoscopic examination, LPRD shows:
- Posterior commissure hypertrophy
- Vocal fold edema
- Hyperemia
- Diffuse laryngeal edema 2
Diagnostic Approach Differences
For GERD:
- Typical esophageal symptoms (heartburn/regurgitation) justify empiric PPI trial without prior testing 5
- 24-hour esophageal pH monitoring defines GERD as pH <4.0 for >4.0% of recording time or DeMeester score >14.72 4
For LPRD:
- An empiric PPI trial is NOT optimal for isolated extraesophageal symptoms because mechanisms other than reflux frequently contribute, making PPI non-response highly likely 5
- Diagnosis requires objective testing: 24-hour hypopharyngeal intraluminal multichannel impedance pH monitoring (24h-MII-pH) showing ≥1 acid or non-acid hypopharyngeal proximal reflux episode 4
- Clinical scoring tools: Reflux Symptom Index (RSI) >13 and Reflux Finding Score (RFS) >7 suggest LPRD 2
- Objective testing should be pursued before prolonged PPI trials 1
Treatment Response Differences
Critical distinction: LPRD shows poor responsiveness to PPI therapy compared to GERD 1. This occurs because:
- Non-acidic and weakly acidic reflux are often the etiology in LPRD 6
- Symptom improvement on PPIs may result from mechanisms other than acid suppression and should not confirm GERD diagnosis 1
- After one failed PPI trial (up to 12 weeks), objective testing for pathologic reflux should be considered, as additional PPI trials are low yield 1
Alternative treatments for LPRD include:
- Barrier agents (sodium alginate-based agents, magnesium alginate with hyaluronic acid) 7, 6
- Lifestyle modifications 1
- Cognitive-behavioral therapy 1
- Neuromodulators 1
Common Pitfalls to Avoid
Do not assume LPRD is simply "GERD of the throat"—they are different diseases with different mechanisms 4, 2
Do not continue empiric PPI trials for isolated extraesophageal symptoms without objective testing—this leads to treatment failure and delayed diagnosis 1, 5
Do not interpret PPI response as diagnostic confirmation—symptom improvement can occur through non-acid suppression mechanisms 1
Recognize that LPRD requires multidisciplinary evaluation involving otolaryngology, gastroenterology, and potentially allergy/immunology, as symptoms often overlap with other conditions 1, 7
Understand that anti-reflux surgery for LPRD requires clear objective evidence of GERD, and lack of PPI response predicts surgical failure 1